These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2338899)

  • 1. MRI characterization of 9L-glioma in rat brain at 4.7 Tesla.
    Rajan SS; Rosa L; Francisco J; Muraki A; Carvlin M; Tuturea E
    Magn Reson Imaging; 1990; 8(2):185-90. PubMed ID: 2338899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative magnetic resonance imaging of rat brain tumors: in vivo NMR relaxometry for the discrimination of normal and pathological tissues.
    Hoehn-Berlage M; Bockhorst K
    Technol Health Care; 1994 Dec; 2(4):247-54. PubMed ID: 7842309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective enhancement of experimental rat brain tumors with Gd-TPPS.
    Bockhorst K; Els T; Hoehn-Berlage M
    J Magn Reson Imaging; 1994; 4(3):451-6. PubMed ID: 8061446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between Gd-enhanced MR imaging and histopathology in treated and untreated 9L rat brain tumors.
    Wilkins DE; Raaphorst GP; Saunders JK; Sutherland GR; Smith IC
    Magn Reson Imaging; 1995; 13(1):89-96. PubMed ID: 7898284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macroscopic tumor volume of malignant glioma determined by contrast-enhanced magnetic resonance imaging with and without magnetization transfer contrast.
    Hawighorst H; Schreiber W; Knopp MV; Essig M; Engenhart-Cabilic R; Brix G; van Kaick G
    Magn Reson Imaging; 1996; 14(10):1119-26. PubMed ID: 9065901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of nonionic low-osmolar gadodiamide injection in animals with intracranial mass lesions.
    Carvlin MJ; Rajan SS; Rosa L; Muraki AS; Francisco J; Rocklage SM
    J Magn Reson Imaging; 1992; 2(1):19-24. PubMed ID: 1623277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inverse correlation between T1 relaxation times before and after administration of contrast media in malignant brain tumors.
    Niemi P; Aronen HJ; Kwong KK; Gazit IE; Pardo FS; Rosen BR
    Acad Radiol; 1996 Aug; 3 Suppl 2():S286-8. PubMed ID: 8796582
    [No Abstract]   [Full Text] [Related]  

  • 8. MRI contrast enhancement by Gd-DTPA-monoclonal antibody in 9L glioma rats.
    Matsumura A; Shibata Y; Nakagawa K; Nose T
    Acta Neurochir Suppl (Wien); 1994; 60():356-8. PubMed ID: 7976589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A magnetic resonance imaging contrast agent differentiates between the vascular properties of fetal striatal tissue transplants and gliomas in rat brain in vivo.
    Norman AB; Thomas SR; Pratt RG; Samaratunga RC; Sanberg PR
    Brain Res; 1989 Nov; 503(1):156-9. PubMed ID: 2611648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-T1-weighted spin-echo MR imaging with contrast material: experimental and preliminary clinical assessment.
    Mihara F; Gupta KL; Righi AM
    Radiat Med; 1994; 12(5):209-12. PubMed ID: 7863024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spin-lock imaging in contrast-enhanced magnetic resonance imaging of human gliomas.
    Aronen HJ; Peltonen TK; Tanttu JI; Sipilä LM; Ruhala MT; Jääskeläinen J; Sepponen R
    Acad Radiol; 1996 Aug; 3 Suppl 2():S170-2. PubMed ID: 8796553
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of Gd-DTPA-induced signal enhancements in rat brain C6 glioma among different pulse sequences in 3-Tesla magnetic resonance imaging.
    Sato H; Enmi J; Teramoto N; Hayashi T; Yamamoto A; Tsuji T; Naito H; Iida H
    Acta Radiol; 2008 Mar; 49(2):172-9. PubMed ID: 18300142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utility of contrast media in MRI at 0.02 T. A preliminary report.
    Kormano M; Niemi P; Paajanen H; Määttänen H; Katevuo K
    Invest Radiol; 1988 Sep; 23 Suppl 1():S289-91. PubMed ID: 3198364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR tissue characterization of intracranial tumors by means of texture analysis.
    Schad LR; Blüml S; Zuna I
    Magn Reson Imaging; 1993; 11(6):889-96. PubMed ID: 8371644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T1 and T2 relaxation times on gadolinium-diethylenetriaminepentaacetic acid enhanced magnetic resonance images of brain tumors.
    Yamada S; Kubota R; Yamada K; Ono S; Hishinuma T; Matsuzawa T; Fujiwara S
    Tohoku J Exp Med; 1990 Feb; 160(2):145-8. PubMed ID: 2353348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of gadodiamide versus gadobutrol for contrast-enhanced MR imaging in a rat brain glioma model at 1.5 and 3 T.
    Morelli JN; Runge VM; Vu L; Loynachan AT; Attenberger UI
    Invest Radiol; 2010 Dec; 45(12):810-8. PubMed ID: 20856127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
    Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Meningeal sign": a characteristic finding of meningiomas on contrast-enhanced MR images.
    Schörner W; Schubeus P; Henkes H; Lanksch W; Felix R
    Neuroradiology; 1990; 32(2):90-3. PubMed ID: 2204839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR imaging of rat brain glioma: Gd-DTPA versus Gd-DOTA.
    Runge VM; Jacobson S; Wood ML; Kaufman D; Adelman LS
    Radiology; 1988 Mar; 166(3):835-8. PubMed ID: 3401296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance brain tumor imaging in canine glioma.
    Whelan HT; Clanton JA; Moore PM; Tolner DJ; Kessler RM; Whetsell WO
    Neurology; 1987 Jul; 37(7):1235-9. PubMed ID: 3601090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.